26 Aug 2022 , 01:08 PM
When made available to UK patients, Lutio has the potential to provide considerable cost reductions.
Tiotropium is used to treat wheezing, shortness of breath, coughing, and chest tightness in people who have a chronic obstructive pulmonary disease (COPD), which includes chronic bronchitis and emphysema.
“We are delighted that the MHRA has approved Lutio for the treatment of chronic obstructive pulmonary disease (COPD), giving patients in the UK with an effective and high-quality therapeutic choice,” said Thierry Volle, Lupin’s President, EMEA.
This is Lupin Healthcare’s second inhalation product for the UK market after the Luforbec pressurized metered dosage inhaler (pMDI).
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.